InvestorsHub Logo
Followers 1
Posts 108
Boards Moderated 0
Alias Born 07/27/2017

Re: None

Friday, 01/05/2018 1:18:59 PM

Friday, January 05, 2018 1:18:59 PM

Post# of 32851
Here is the NR I was referring to,


Radient to produce pot extracts for Terra Life Sciences



2017-12-11 07:39 ET - News Release


Mr. Mike Cabigon reports

RADIENT TECHNOLOGIES INC. ANNOUNCES MASTER SERVICES AGREEMENT WITH TERRA LIFE SCIENCES

Radient Technologies Inc. has signed a master services agreement to produce cannabis extracts for the Terra Life Sciences group, a private, Alberta-based pharmaceutical manufacturer whose ACMPR (Access to Cannabis for Medical Purposes Regulations) licence is expected in the near future.

Under the terms of the agreement, Radient will use its proprietary microwave-based extraction platform and decades of extraction expertise to deliver extraction as a service to Terra Life Sciences. From its Edmonton facility, Radient will process and refine Terra Life Sciences' cultivated cannabis material into permitted cannabis oil products at industrial-scale throughput and high yields, while maintaining rigorous quality and product safety standards.

With its subsidiary Olds SoftGels Inc. (OSG) and OSG's production capacity of over 2.5 billion softgel capsules a year from two GMP-certified facilities, Terra Life Sciences is well positioned to develop innovative, pharma-grade cannabis and CBD-based products at scale, enabled by the economic and operational advantages provided by Radient's platform.

"We are excited to be a partner in Terra Life Sciences' product development and value chain as they address the rapidly growing medical applications of cannabis and CBD-based products," said Mike Cabigon, chief operating officer of Radient. "Furthermore, we anticipate a number of important synergies between the two companies as we address consumer needs."

Dr. Anil Jain, president and chief executive officer of Terra Life Sciences, added: "Through the use of MAP, Radient has a proven, high value extraction system that will help bring to market a number of exciting products. It is important for us to solidify this relationship because it will provide us access to large-scale extraction capacity for producing high-quality pharma-grade medicine."

About Radient Technologies Inc.